Here’s the introduction for those of you who’d like to know what the National Law Review is saying
The New York Legislature is considering and is expected to pass the Marijuana Regulation and Taxation Act (MRTA). If passed, the MRTA will create a new framework to regulate the production and sale of cannabis. The legislation will create a new adult-use cannabis program and expand the existing medical cannabis and cannabinoid (CBD) hemp programs.
The Office of Cannabis Management
The MRTA will place the three programs under the control of the Office of Cannabis Management (OCM), within the Division of Alcohol Beverage Control. The OCM will be led by an executive director, assisted by a chief equity officer and governed by a five-member Cannabis Control Board (the Board).
There will also be a 13-member Advisory Board to include experts in several fields including health, social equity, cannabis, and agriculture, with geographic and diverse membership.
The powers of the OCM include the establishment of cultivation and processing standards, caps, and limitations; the licensure of all business entities in the production and distribution process; the inspection and enforcement of the adult-use, medical, and CBD hemp programs; and the promulgation of all associated regulations. The OCM will determine details such as the types of products allowed in each program, advertising and marketing rules, product labeling rules, the number of licenses, the process for licensure, and the implementation of a social equity program.